Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

Ozturk Mehmet; Harris Martin; Vuong Nguyen; Barthelmes Daniel; Gillies Mark C.; Mehta Hemal

首页> 外文期刊>Investigative ophthalmology & visual science >Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

【24h】

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

机译：患者的现实世界视觉结果与新血管（Eylea）接受AfliBercept（Eylea）玻璃体内注射以固定的间隔根据英国许可证

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共3页
作者
Ozturk Mehmet; Harris Martin; Vuong Nguyen; Barthelmes Daniel; Gillies Mark C.; Mehta Hemal;
展开▼
作者单位

Royal Free NHS Fdn Trust Ophthalmol London England;

Royal Free NHS Fdn Trust Ophthalmol London England;

Univ Sydney Save Sight Inst Sydney NSW Australia;

Univ Sydney Save Sight Inst Sydney NSW Australia;

Univ Sydney Save Sight Inst Sydney NSW Australia;

Royal Free NHS Fdn Trust Ophthalmol London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
专利

1. Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license [J] . Ozturk Mehmet, Harris Martin, Vuong Nguyen, Investigative ophthalmology & visual science . 2017,第8期

机译：患者的现实世界视觉结果与新血管（Eylea）接受AfliBercept（Eylea）玻璃体内注射以固定的间隔根据英国许可证
2. Two years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study dataTwo years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study data [J] . Kanda Koji, Sato Tomohito, Taguchi Manzo, Investigative ophthalmology & visual science . 2017,第8期

机译：根据固定的2个月间隔接受AfliBercept的眼睛两年的结果与新生血管年龄相关的黄斑变性：观察研究DataTwo岁月后的眼睛，接受AfliBercept的目的，根据固定的2个月的新生血管年龄相关性黄斑变性：观察研究数据
3. Two years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study dataTwo years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study data [J] . Kanda Koji, Sato Tomohito, Taguchi Manzo, Investigative ophthalmology & visual science . 2017,第8期

机译：根据固定的2个月间隔接受AfliBercept的眼睛两年的结果与新生血管年龄相关的黄斑变性：观察研究DataTwo岁月后的眼睛，接受AfliBercept的目的，根据固定的2个月的新生血管年龄相关性黄斑变性：观察研究数据
4. Associations among comorbidities, visual acuity, and quality of life in patients with age-related macular degeneration and central vision loss. [D] . Miskala, Paivi Helena. 2002

机译：与年龄相关的黄斑变性和中心视力丧失的患者的合并症，视敏度和生活质量之间的关联。
5. Comment on: ‘One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration’ [O] . A R Nestel 2018

机译：评论：接受固定剂量阿柏西普治疗与新生血管性年龄相关的黄斑变性的患者的一年现实结果
6. One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular agerelated macular Q2 degeneration [O] . Lotery, Andrew, Rufai, Sohaib, Almuhtaseb, Hussein, 2017

机译：接受固定剂量aflibercept治疗新生血管性年龄相关性黄斑Q2变性患者的一年现实世界结果

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

著录项

相似文献

相关主题

期刊订阅